HER2-Positive Metastatic Breast Cancer: Available Treatments and Current Developments.

Essadi, Ismail; Benbrahim, Zineb; Kaakoua, Mohamed; Reverdy, Thibaut; Corbaux, Pauline; Freyer, Gilles

Essadi, Ismail; Benbrahim, Zineb; Kaakoua, Mohamed; Reverdy, Thibaut; Corbaux, Pauline; Freyer, Gilles.

Afiliación

Essadi I; Medical Oncology, Ibn Sina Military Hospital, Faculty of Medicine, Cadi Ayyad University, Marrakesh 40080, Morocco.
Benbrahim Z; Medical Oncology, Faculty of Medicine, Sidi Mohamed Benabdellah University, Fez 30000, Morocco.
Kaakoua M; Medical Oncology, Ibn Sina Military Hospital, Faculty of Medicine, Cadi Ayyad University, Marrakesh 40080, Morocco.
Reverdy T; Medical Oncology, HCL Cancer Institute, 69310 Lyon, France.
Corbaux P; Medical Oncology, University Hospital Center, 42000 Saint-Etienne, France.
Freyer G; Medical Oncology, HCL Cancer Institute, 69310 Lyon, France.

Cancers (Basel) ; 15(6)2023 Mar 13.

Article en En | MEDLINE | ID: mdl-36980624

Palabras clave

HER2-positive; metastatic breast cancer; targeted therapies

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Cancers (Basel) Año: 2023 Tipo del documento: Article País de afiliación: Marruecos